JOHNSON & JOHNSON LIKELY TO SHARE ITS COVID-19 VACCINE RESULTS NEXT WEEK

Highlights

• After announcing the results, the US pharmaceutical may apply for an emergency approval for its single-dose vaccine

• Johnson & Johnson CFO Joseph Wolk said “We plan to report out by early next week in terms of our results.”

• Wolk said that the stage 3 clinical trials included 45,000 people across 80 nations and potentially included cases of new strains those were ident....